Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed.
Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed. A new commentary from RAND takes a look at the benefits of using telehealth and what research is still needed for telealth payment policies to be created.
Past research has shown that telehealth could increase access for people in underserved areas, save time for patients, and help avoid some visits totally. The problem is that providers have little incentive to use this technology because there is no mechanism to bill for work done outside of in-person visits. Furthermore, within the Medicare system there are limitations on which patients can use the telehealth services that are reimbursed.
"However, despite the push for increased telehealth 'parity' (reimbursing telehealth services in an equivalent fashion to an in-person appointment), we know that suddenly reimbursing all telehealth exactly like in-person visits is dangerous," wrote Shira Fischer, associate physician researcher at RAND.
More research is needed in order to determine in what cases telehealth is a good, safe, and cost-effective option. She added that emerging health payment models, such as accountable care organizations, may hold the greatest potential for telehealth services.
Read the full commentary at RAND: http://bit.ly/1Qev5Zw
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More